JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$1.18B |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$1.07B |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$963M |
| 5 |
Medtronic
MDT
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.5B |
| 2 |
Microsoft
MSFT
|
+$873M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$716M |
| 4 |
Chubb
CB
|
+$675M |
| 5 |
Lowe's Companies
LOW
|
+$661M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.13% |
| 2 | Financials | 15.03% |
| 3 | Technology | 12.86% |
| 4 | Healthcare | 9.44% |
| 5 | Consumer Discretionary | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
FLXN
2751
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $3.39M | ﹤0.01% |
151,397
-14,774
| -9% | -$361K |
2015 Q4
9 quarters
|
|
2752
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.7B
| $3.39M | ﹤0.01% |
28,413
-2,705
| -9% | -$327K |
2013 Q3
18 quarters
|
|
|
JNCE
2753
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $3.38M | ﹤0.01% |
151,415
-11,308
| -7% | -$251K |
2017 Q1
4 quarters
|
|
2754
StoneX
SNEX
$7.94B
| $3.38M | ﹤0.01% |
401,021
-661,076
| -62% | -$5.56M |
2015 Q2
11 quarters
|
|
2755
CALL
United Therapeutics
UTHR
$23.2B
| $3.37M | ﹤0.01% |
+30,000
| New | +$3.81M |
2018 Q1
0 quarters
|
|
2756
Varonis Systems
VRNS
$5.46B
| $3.37M | ﹤0.01% |
167,115
-87,822
| -34% | -$1.63M |
2014 Q1
16 quarters
|
|
|
CCEC
2757
Capital Clean Energy Carriers
CCEC
$1.26B
| $3.37M | ﹤0.01% |
154,281
+1,158
| +0.8% | +$26.7K |
2015 Q1
12 quarters
|
|
2758
Perion Network
PERI
$334M
| $3.36M | ﹤0.01% |
1,401,022
| – | – |
2013 Q4
17 quarters
|
|
|
MOBL
2759
DELISTED
MobileIron, Inc.
MOBL
| $3.36M | ﹤0.01% |
678,378
+297,971
| +78% | +$1.36M |
2016 Q4
5 quarters
|
|
|
CNCE
2760
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $3.35M | ﹤0.01% |
146,508
-11,558
| -7% | -$257K |
2017 Q4
1 quarter
|
|
|
MFA
2761
MFA Financial
MFA
$773M
| $3.35M | ﹤0.01% |
111,206
-135,985
| -55% | -$4.04M |
2013 Q2
19 quarters
|
|
2762
PUT
Teva Pharmaceutical Industries Limited
TEVA
$46.1B
| $3.35M | ﹤0.01% |
195,700
+700
| +0.4% | +$13.7K |
2016 Q4
5 quarters
|
|
|
INFN
2763
DELISTED
Infinera Corporation Common Stock
INFN
| $3.34M | ﹤0.01% |
307,710
-2,602,612
| -89% | -$23.1M |
2013 Q2
19 quarters
|
|
|
SGYP
2764
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $3.34M | ﹤0.01% |
1,826,266
-937,272
| -34% | -$1.98M |
2015 Q2
11 quarters
|
|
2765
CALL
NetEase
NTES
$75.1B
| $3.34M | ﹤0.01% |
59,500
-125,000
| -68% | -$7.85M |
2017 Q4
1 quarter
|
|
2766
Aclaris Therapeutics
ACRS
$646M
| $3.33M | ﹤0.01% |
190,281
+185,266
| +3,694% | +$3.93M |
2017 Q4
1 quarter
|
|
2767
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.3B
| $3.33M | ﹤0.01% |
108,933
+25,618
| +31% | +$800K |
2017 Q4
1 quarter
|
|
2768
Ligand Pharmaceuticals
LGND
$6.04B
| $3.33M | ﹤0.01% |
32,272
-36,885
| -53% | -$3.65M |
2015 Q4
9 quarters
|
|
2769
CALL
Mohawk Industries
MHK
$8.56B
| $3.32M | ﹤0.01% |
14,300
| – | – |
2017 Q4
1 quarter
|
|
|
VRN
2770
DELISTED
Veren
VRN
| $3.32M | ﹤0.01% |
488,306
+278,130
| +132% | +$2.11M |
2014 Q1
16 quarters
|
|
|
ARC
2771
DELISTED
ARC Document Solutions, Inc.
ARC
| $3.32M | ﹤0.01% |
1,508,987
+43,664
| +3% | +$103K |
2013 Q2
19 quarters
|
|
2772
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.3B
| $3.32M | ﹤0.01% |
+100,000
| New | +$3.37M |
2018 Q1
0 quarters
|
|
2773
Myers Industries
MYE
$1.19B
| $3.31M | ﹤0.01% |
156,543
-17,686
| -10% | -$366K |
2013 Q2
19 quarters
|
|
|
CPE
2774
DELISTED
Callon Petroleum Company
CPE
| $3.31M | ﹤0.01% |
24,994
-2,387
| -9% | -$280K |
2015 Q1
12 quarters
|
|
|
GOLD
2775
DELISTED
Randgold Resources Ltd
GOLD
| $3.31M | ﹤0.01% |
39,737
-5,826
| -13% | -$525K |
2013 Q2
19 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2018 Portfolio in Review
As of Q1 2018, JP Morgan Chase held 5,855 positions worth $467B, down 1.7% from $475B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q1 2018 filing shows 386 new, 1,953 increased, 2,569 reduced and 469 closed positions. Its largest new stake was Avaya Holdings Corp. Common Stock: 9,632,519 shares worth $216M. The largest sale was Apple, an estimated $1.5B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, up from 22% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q1 2018 buy was Avaya Holdings Corp. Common Stock: 9,632,519 shares worth $216M.
- JP Morgan Chase added most to iShares MSCI Japan ETF in Q1 2018, an estimated $1.18B increase.
- JP Morgan Chase's biggest Q1 2018 reduction was Apple, cutting an estimated $1.5B.
- JP Morgan Chase fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $168M.
- JP Morgan Chase's ten largest holdings make up 18% of its $467B portfolio in Q1 2018.
- JP Morgan Chase opened 386 new positions and closed 469 in Q1 2018.
- JP Morgan Chase's portfolio value fell 1.7% quarter-over-quarter to $467B.
Based on JP Morgan Chase's 13F filing for Q1 2018, filed 10 May 2018.